Single cell mass spectrometry analysis of drug-resistant cancer cells: Metabolomics studies of synergetic effect of combinational treatment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Single cell mass spectrometry analysis of drug-resistant cancer cells: Metabolomics studies of synergetic effect of combinational treatment
Authors
Keywords
Single cell mass spectrometry, Metabolomics, Lipidomics, Drug-resistant cancer cells, Metformin, Fatty-acid synthase
Journal
ANALYTICA CHIMICA ACTA
Volume 1201, Issue -, Pages 339621
Publisher
Elsevier BV
Online
2022-02-24
DOI
10.1016/j.aca.2022.339621
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exploring and modelling colon cancer inter-tumour heterogeneity: opportunities and challenges
- (2020) Joyce Y. Buikhuisen et al. Oncogenesis
- Mass Spectrometry Measurement of Single Suspended Cells Using a Combined Cell Manipulation System and a Single-Probe Device
- (2019) Shawna J. Standke et al. ANALYTICAL CHEMISTRY
- Integrating a generalized data analysis workflow with the Single-probe mass spectrometry experiment for single cell metabolomics
- (2019) Renmeng Liu et al. ANALYTICA CHIMICA ACTA
- Quantification of Drug Molecules in Live Single Cells Using the Single-Probe Mass Spectrometry Technique
- (2019) Ning Pan et al. ANALYTICAL CHEMISTRY
- Towards early monitoring of chemotherapy-induced drug resistance based on single cell metabolomics: Combining single-probe mass spectrometry with machine learning
- (2019) Renmeng Liu et al. ANALYTICA CHIMICA ACTA
- Cell Heterogeneity and Phenotypic Plasticity in Metastasis Formation: The Case of Colon Cancer
- (2019) Miriam Teeuwssen et al. Cancers
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metformin as an Anticancer Agent
- (2018) Ales Vancura et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Metabolic Profiles Associated With Metformin Efficacy in Cancer
- (2018) Sylvia Andrzejewski et al. Frontiers in Endocrinology
- Metabolomic Studies of Live Single Cancer Stem Cells Using Mass Spectrometry
- (2018) Mei Sun et al. ANALYTICAL CHEMISTRY
- Live single cell mass spectrometry reveals cancer‐specific metabolic profiles of circulating tumor cells
- (2018) Yasmine Abouleila et al. CANCER SCIENCE
- Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer
- (2017) Yong Yang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis
- (2017) Kyung Ha Lee et al. Molecular Medicine Reports
- HMDB 4.0: the human metabolome database for 2018
- (2017) David S Wishart et al. NUCLEIC ACIDS RESEARCH
- Fatty acid synthase – Modern tumor cell biology insights into a classical oncology target
- (2017) Douglas Buckley et al. PHARMACOLOGY & THERAPEUTICS
- Single-neuron identification of chemical constituents, physiological changes, and metabolism using mass spectrometry
- (2017) Hongying Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Geena 2, improved automated analysis of MALDI/TOF mass spectra
- (2016) Paolo Romano et al. BMC BIOINFORMATICS
- The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling
- (2016) Alexander M. Scherbakov et al. IUBMB LIFE
- Removing the bottlenecks of cell culture metabolomics: fast normalization procedure, correlation of metabolites to cell number, and impact of the cell harvesting method
- (2016) Caroline Muschet et al. Metabolomics
- Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking
- (2016) Mingxun Wang et al. NATURE BIOTECHNOLOGY
- The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development
- (2016) Jun Gong et al. Targeted Oncology
- Inhibition of Fatty Acid Synthase Decreases Expression of Stemness Markers in Glioma Stem Cells
- (2016) Yuki Yasumoto et al. PLoS One
- Energy Charge, Redox State, and Metabolite Turnover in Single Human Hepatocytes Revealed by Capillary Microsampling Mass Spectrometry
- (2015) Linwen Zhang et al. ANALYTICAL CHEMISTRY
- Metformin and prostate cancer stem cells: a novel therapeutic target
- (2015) M J Mayer et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells
- (2015) Camille Loubière et al. Oncotarget
- In Situ metabolic analysis of single plant cells by capillary microsampling and electrospray ionization mass spectrometry with ion mobility separation
- (2014) Linwen Zhang et al. ANALYST
- The Single-Probe: A Miniaturized Multifunctional Device for Single Cell Mass Spectrometry Analysis
- (2014) Ning Pan et al. ANALYTICAL CHEMISTRY
- Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
- (2014) Fotios Loupakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle
- (2013) S. M. Hadad et al. Clinical & Translational Oncology
- Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status
- (2013) AMÉLIE PETITPREZ et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Contextual inhibition of fatty acid synthesis by metformin involves glucose-derived acetyl-CoA and cholesterol in pancreatic tumor cells
- (2013) Mary Jo Cantoria et al. Metabolomics
- Intestinal glucuronidation protects against chemotherapy-induced toxicity by irinotecan (CPT-11)
- (2013) S. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms and insights into drug resistance in cancer
- (2013) Hiba Zahreddine et al. Frontiers in Pharmacology
- Lipid metabolism in cancer
- (2012) Claudio R. Santos et al. FEBS Journal
- Differentiated Human Colorectal Cancer Cells Protect Tumor-Initiating Cells From Irinotecan
- (2011) Benjamin L. Emmink et al. GASTROENTEROLOGY
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- Fatty acid synthase as a potential therapeutic target in cancer
- (2010) Richard Flavin et al. Future Oncology
- AMPK as a metabolic tumor suppressor: control of metabolism and cell growth
- (2010) Zhijun Luo et al. Future Oncology
- In Situ Metabolic Profiling of Single Cells by Laser Ablation Electrospray Ionization Mass Spectrometry
- (2009) Bindesh Shrestha et al. ANALYTICAL CHEMISTRY
- De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy
- (2009) T Mashima et al. BRITISH JOURNAL OF CANCER
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Preclinicalversusclinical drug combination studies
- (2008) Ting-Chao Chou LEUKEMIA & LYMPHOMA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More